Results for tag: "Idoxifene"

Idoxifene is a selective estrogen receptor modulator (SERM) used to treat endocrine and metabolic disorders. It is used to treat postmenopausal women with osteoporosis, as well as to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk of invasive breast cancer. Idoxifene works by blocking the effects of estrogen in certain parts of the body, such as the breast and uterus, while also mimicking the effects of estrogen in other parts of the body, such as the bones. Idoxifene is available in both oral and injectable forms, and is typically prescribed in combination with calcium and vitamin D supplements. Common side effects of idoxifene include hot flashes, leg cramps, and nausea. The idoxifene market is a growing segment of the endocrine and metabolic disorders drugs market. It is expected to benefit from the increasing prevalence of osteoporosis and breast cancer, as well as the growing demand for SERMs. Some companies in the idoxifene market include Pfizer, Novartis, and Eli Lilly. Show Less Read more